May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Reduced retinal angiogenesis in MMP–2 deficient mice
Author Affiliations & Notes
  • K. Ohno–Matsui
    Dept of Ophthalmology,
    Tokyo Medical and Dental Univ, Bunkyo–Ku, Japan
  • T. Uetama
    Dept of Ophthalmology,
    Tokyo Medical and Dental Univ, Bunkyo–Ku, Japan
  • T. Yoshida
    Dept of Ophthalmology,
    Tokyo Medical and Dental Univ, Bunkyo–Ku, Japan
  • M. Hayano
    Dept of Ophthalmology,
    Tokyo Medical and Dental Univ, Bunkyo–Ku, Japan
  • T. Itoh
    Discovery Research Laboratory, Shionogi Pharmaceutical company, Osaka, Japan
  • I. Morita
    Dept of Cellular Physiological Chemistry,
    Tokyo Medical and Dental Univ, Bunkyo–Ku, Japan
  • M. Mochizuki
    Dept of Ophthalmology,
    Tokyo Medical and Dental Univ, Bunkyo–Ku, Japan
  • Footnotes
    Commercial Relationships  K. Ohno–Matsui, None; T. Uetama, None; T. Yoshida, None; M. Hayano, None; T. Itoh, None; I. Morita, None; M. Mochizuki, None.
  • Footnotes
    Support  Society for the Promotion of Science, #14571659
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 1188. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      K. Ohno–Matsui, T. Uetama, T. Yoshida, M. Hayano, T. Itoh, I. Morita, M. Mochizuki; Reduced retinal angiogenesis in MMP–2 deficient mice . Invest. Ophthalmol. Vis. Sci. 2004;45(13):1188.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To study the putative role of endogenous matrix metalloproteinases (MMPs) in retinal neovascularization, we used an established mouse model to compare the retinal neovascularization observed in wild–type mice to that in mice lacking the MMP–2 or MMP–9 gene. Methods: C57Bl/6 (MMP–2+/+, MMP–9+/+), MMP–2–deficient (MMP2–/–), and MMP–9–deficient (MMP–9–/–) mice were used. After oxygen–induced retinopathy was induced in the mice, their eyes were rapidly removed and frozen in optimal cutting temperature embedding compound. Sections were histochemically stained with specific markers for vascular cells and angiogenesis–related factors. The area of new retinal vessels was measured using image analysis software and compared between groups. Results: Retinal neovascularization was not significantly different between wild–type mice and MMP–9–/– mice. The MMP–2–/– mice developed significantly less extraretinal neovascularization than did wild–type mice. The mean number of extraretinal neovascular buds per cross section was significantly lower in MMP2–/– mice compared with wild–type mice (P<0.05). The expression of other angiogenesis–related factors, vascular endothelial growth factor and pigment epithelium–derived factor, was not different between wild–type mice and MMP–2 –/– mice. Conclusions: MMP–2 might be important for the regulation of retinal neovascularization. Pharmacologic intervention using MMP inhibitors might be a future therapeutic approach for angiogenic retinal diseases.

Keywords: retinal neovascularization • transgenics/knock–outs • extracellular matrix 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×